Literature DB >> 1739137

Establishment and characterization of five new human renal tumor xenografts.

A J Beniers1, W P Peelen, H E Schaafsma, J L Beck, F C Ramaekers, F M Debruyne, J A Schalken.   

Abstract

Ten different human renal cell carcinoma (RCC) primary tumors were xenografted into BALB/c nu/nu mice. Five of the tumors (NU-10, NU-12, NU-20, NU-22, and NU-28) gave rise to serially transplantable tumors that were further characterized. Histology, DNA index, immunohistochemical characteristics, growth rate, and clonogenic potential were followed from primary tumor to the 5th to 15th transplant passage. Only one of the tumors (NU-20) showed remarkable instability for all tested parameters in the first five transplant passages. Histology of the other tumors was essentially the same to the histology of the primary tumors, although differences between human and host-derived vessels were apparent. DNA index values in general showed a trend toward an aneuploid character of the xenografts. Immunohistochemical analyses showed a loss of intensity of staining but a concomitant rise in the fraction of positively staining cells with antibodies against cytokeratins, vimentin, tumor-associated antigens, and human leukocyte antigen (HLA) class I antigens. Human leukocyte antigen class II antigen expression showed a loss of intensity as well as a decrease in the fraction of positive cells. Tumor doubling time was lowest in transplant passage number 0, and stable growth was noticed in transplant passages 1 through 4. Clonogenic potential of four of the lines was higher for the xenografts than for the primary tumors. The authors conclude that, on xenografting, histologic characteristics of the primary tumor are essentially conserved. Progression in the first transplant passages, however, results in tumors with a more aggressive character.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1739137      PMCID: PMC1886418     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  DETERMINATION OF THE OXYHAEMOGLOBIN DISSOCIATION CURVES FOR MOUSE AND RAT BLOOD.

Authors:  L H GRAY; J M STEADMAN
Journal:  J Physiol       Date:  1964-12       Impact factor: 5.182

2.  Epitopic analysis of detergent-solubilized HLA molecules by solid-phase radioimmunoassay.

Authors:  F A Lemonnier; N Rebai; P P Le Bouteiller; B Malissen; D H Caillol; F M Kourilsky
Journal:  J Immunol Methods       Date:  1982-10-15       Impact factor: 2.303

3.  In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.

Authors:  S Habu; H Fukui; K Shimamura; M Kasai; Y Nagai; K Okumura; N Tamaoki
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

4.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

5.  Is renal cell (Grawitz) tumor a carcinosarcoma? Evidence from analysis of intermediate filament types.

Authors:  C J Herman; O Moesker; A Kant; A Huysmans; G P Vooijs; F C Ramaekers
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1983

6.  Transplantation of human renal carcinomas into athymic mice.

Authors:  R V Clayman; R S Figenshau; A Bear; C Limas
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

7.  Transplantability of human lymphoid cell line, lymphoma, and leukemia in splenectomized and/or irradiated nude mice.

Authors:  S Watanabe; Y Shimosato; M Kuroki; Y Sato; T Nakajima
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

Review 8.  Antibodies to intermediate filament proteins in the immunohistochemical identification of human tumours: an overview.

Authors:  F C Ramaekers; J J Puts; O Moesker; A Kant; A Huysmans; D Haag; P H Jap; C J Herman; G P Vooijs
Journal:  Histochem J       Date:  1983-07

9.  Specificity of cytotoxic T cells from athymic mice.

Authors:  T Hünig; M J Bevan
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

10.  Vascular structure of five human malignant melanomas grown in athymic nude mice.

Authors:  O V Solesvik; E K Rofstad; T Brustad
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

View more
  8 in total

Review 1.  Patient-derived tumour xenografts as models for oncology drug development.

Authors:  John J Tentler; Aik Choon Tan; Colin D Weekes; Antonio Jimeno; Stephen Leong; Todd M Pitts; John J Arcaroli; Wells A Messersmith; S Gail Eckhardt
Journal:  Nat Rev Clin Oncol       Date:  2012-04-17       Impact factor: 66.675

2.  A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro.

Authors:  Vincent C Daniel; Luigi Marchionni; Jared S Hierman; Jonathan T Rhodes; Wendy L Devereux; Charles M Rudin; Rex Yung; Giovanni Parmigiani; Marion Dorsch; Craig D Peacock; D Neil Watkins
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

3.  ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in mice.

Authors:  Alexander B Stillebroer; Gerben M Franssen; Peter F A Mulders; Wim J G Oyen; Guus A M S van Dongen; Peter Laverman; Egbert Oosterwijk; Otto C Boerman
Journal:  Cancer Biother Radiopharm       Date:  2013-05-22       Impact factor: 3.099

4.  Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model.

Authors:  Gilda G Hillman; Yu Wang; Mingxin Che; Julian J Raffoul; Mark Yudelev; Omer Kucuk; Fazlul H Sarkar
Journal:  BMC Cancer       Date:  2007-01-09       Impact factor: 4.430

5.  Successful combination of sunitinib and girentuximab in two renal cell carcinoma animal models: a rationale for combination treatment of patients with advanced RCC.

Authors:  Jeannette C Oosterwijk-Wakka; Mirjam C A de Weijert; Gerben M Franssen; William P J Leenders; Jeroen A W M van der Laak; Otto C Boerman; Peter F A Mulders; Egbert Oosterwijk
Journal:  Neoplasia       Date:  2015-02       Impact factor: 5.715

6.  Spontaneous Post-Transplant Disorders in NOD.Cg- Prkdcscid Il2rgtm1Sug/JicTac (NOG) Mice Engrafted with Patient-Derived Metastatic Melanomas.

Authors:  Enrico Radaelli; Els Hermans; Lorna Omodho; Annick Francis; Sara Vander Borght; Jean-Christophe Marine; Joost van den Oord; Frédéric Amant
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

Review 7.  Choosing the right cell line for renal cell cancer research.

Authors:  Klaudia K Brodaczewska; Cezary Szczylik; Michal Fiedorowicz; Camillo Porta; Anna M Czarnecka
Journal:  Mol Cancer       Date:  2016-12-19       Impact factor: 27.401

8.  A new computational tool for the phenomenological analysis of multipassage tumor growth curves.

Authors:  Antonio S Gliozzi; Caterina Guiot; Pier Paolo Delsanto
Journal:  PLoS One       Date:  2009-04-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.